171 related articles for article (PubMed ID: 7682051)
1. Plasminogen activation in lesional skin of Pemphigus vulgaris type Neumann.
Reinartz J; Näher H; Mai H; Kramer MD
Arch Dermatol Res; 1993; 284(8):432-9. PubMed ID: 7682051
[TBL] [Abstract][Full Text] [Related]
2. The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.
Kramer MD; Reinartz J
J Clin Invest; 1993 Aug; 92(2):978-83. PubMed ID: 7688770
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis.
Gissler HM; Frank R; Kramer MD
Br J Dermatol; 1993 Jun; 128(6):612-8. PubMed ID: 7687853
[TBL] [Abstract][Full Text] [Related]
4. Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.
Harpel PC
J Clin Invest; 1981 Jul; 68(1):46-55. PubMed ID: 6166634
[TBL] [Abstract][Full Text] [Related]
5. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
Thorsen S; Müllertz S; Suenson E; Kok P
Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
[TBL] [Abstract][Full Text] [Related]
6. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
Müllertz S; Thorsen S; Sottrup-Jensen L
Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
[TBL] [Abstract][Full Text] [Related]
7. Lower molecular weight species of alpha 2-macroglobulin-plasmin complexes in human plasma activated by urokinase.
Yamamoto J; Okamoto U
Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):1090-9. PubMed ID: 2414954
[No Abstract] [Full Text] [Related]
8. [The autoimmune dermatosis bullous pemphigoid: deposition and activation of plasminogen in affected epidermis].
Reinartz J; Kramer MD
Immun Infekt; 1994 Feb; 22(1):20-2. PubMed ID: 7523283
[TBL] [Abstract][Full Text] [Related]
9. The plasmin system in human adenocarcinomas and their metastases. A comparative immunofluorescence study.
Burtin P; Chavanel G; André-Bougaran J; Gentile A
Int J Cancer; 1987 Feb; 39(2):170-8. PubMed ID: 2433233
[TBL] [Abstract][Full Text] [Related]
10. [Concentration of plasmin complexes with alpha-2-macroglobulin and alpha-2-antiplasmin in blood plasma and serum].
Zhabin SG; Zorin NA
Klin Lab Diagn; 1995; (4):43-4. PubMed ID: 7545523
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator system in pemphigus vulgaris.
Schaefer BM; Jaeger CJ; Kramer MD
Br J Dermatol; 1996 Nov; 135(5):726-32. PubMed ID: 8977672
[TBL] [Abstract][Full Text] [Related]
12. [The effect of plasmin and its complexes with alpha 2-antiplasmin and alpha 2-macroglobulin on secretion of proteinase and plasminogen inhibitors from peripheral mononuclear cells].
Zhabin SG; Zorin NA; Musatov MI
Vopr Med Khim; 1995; 41(3):34-7. PubMed ID: 8585176
[TBL] [Abstract][Full Text] [Related]
13. Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice.
Mahoney MG; Wang ZH; Stanley JR
J Invest Dermatol; 1999 Jul; 113(1):22-5. PubMed ID: 10417613
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen, alpha(2)-antiplasmin and complexes of plasmin-alpha(2)-antiplasmin (PAP) in amniotic fluid and blood plasma of parturient women.
Uszynski M; Klyszejko A; Zekanowska E
Eur J Obstet Gynecol Reprod Biol; 2000 Dec; 93(2):167-71. PubMed ID: 11074138
[TBL] [Abstract][Full Text] [Related]
15. The plasmin-antiplasmin system: structural and functional aspects.
Schaller J; Gerber SS
Cell Mol Life Sci; 2011 Mar; 68(5):785-801. PubMed ID: 21136135
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
Rouy D; Anglés-Cano E
Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
[TBL] [Abstract][Full Text] [Related]
17. Production of the modified form of human plasminogen by alpha 2-macroglobulin-plasmin complexes.
Yamamoto J; Okamoto U; Morita S; Asada N; Yamaoka M
Jpn J Physiol; 1985; 35(6):1013-21. PubMed ID: 2422420
[TBL] [Abstract][Full Text] [Related]
18. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
Bangert K; Thorsen S
Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
[TBL] [Abstract][Full Text] [Related]
19. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.
Leebeek FW; Kluft C; Knot EA; de Maat MP; Wilson JH
Gastroenterology; 1991 Nov; 101(5):1382-90. PubMed ID: 1718809
[TBL] [Abstract][Full Text] [Related]
20. The fibrinolytic system in man.
Collen D; Lijnen HR
Crit Rev Oncol Hematol; 1986; 4(3):249-301. PubMed ID: 2420482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
